[조사자료] 세계의 측방 유동 분석 시장 (~2027년) : 제품별 (키트, 리더), 용도별 (임상시험, 수의학 진단, 식품 안전 및 환경 테스트), 기술별 (샌드위치, 멀티플렉스 분석), 최종 용도별 (병원, 재택 의료)

■ 영문 제목 : Lateral Flow Assays Market by Product (Kits, Readers), Application (Clinical Testing, Veterinary Diagnostics, Food Safety & Environmental Testing), Technique (Sandwich, Multiplex Detection Assay), End User (Hospitals, Home care) - Global Forecast to 2027
	■ 상품코드 : MD4158-23 ■ 조사/발행회사 : MarketsandMarkets ■ 발행일 : 2023년 2월 ■ 페이지수 : 375 ■ 작성언어 : 영어 ■ 보고서 형태 : PDF ■ 납품 방식 : E메일 ■ 조사대상 지역 : 세계 ■ 산업 분야 : 화학

■ 판매가격 / 옵션 (부가세 10% 별도)

Single User (1인 열람용)	USD4,950 ⇒환산￦6,682,500	견적의뢰/주문/질문
Five User (5인 열람용)	USD6,650 ⇒환산￦8,977,500	견적의뢰/주문/질문
Corporate License (동일 법인내 공유가능)	USD8,150 ⇒환산￦11,002,500	견적의뢰/구입/질문

※가격옵션 설명
- 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다.
- 지불방법은 계좌이체/무통장입금 또는 카드결제입니다.

MarketsandMarkets사의 본 보고서는 세계의 측방 유동 분석 시장 규모가 2022년에 205억 달러에 이르며, 2027년까지 226억 달러로 확대될 것으로 추정하고 있습니다. 덧붙여 예측 기간 동안 연평균 2.0%로 성장할 것으로 전망하고 있습니다. 본 조사 보고서는 세계의 측방 유동 분석 시장에 대해 조사하여, 소개, 조사 방법, 개요, 프리미엄 인사이트, 시장 개요, 제품별 (키트 및 시약, 측방유동 리더, 임상 진단용 측방유동 리더) 분석, 용도별 (임상시험, 수의 진단, 식품 안전 및 환경 시험) 분석, 기술별 (샌드위치 검분석정, 경쟁 분석, 멀티플렉스 검출 분석) 분석, 샘플별 (혈액 샘플, 소변 샘플, 타액 샘플) 분석, 지역별 (북미, 유럽, 아시아 태평양, 중남미, 중동, 아프리카) 분석, 경쟁 현황, 기업 정보 등의 내용을 게재하고 있습니다. 또한 본 문서에 게재된 기업 정보로 Abbott Laboratories (US), F. Hoffman-La Roche AG (Switzerland), Danaher Corporation (US), Siemens AG (Germany), BD (US) 등이 포함되어 있습니다.
· 소개
· 조사 방법
· 개요
· 프리미엄 인사이트
· 시장 개요
· 세계의 측방 유동 분석 시장 규모 : 제품별
- 키트 및 시약의 시장 규모
- 측방유동 리더의 시장 규모
- 임상 진단용 측방유동 리더의 시장 규모
· 세계의 측방 유동 분석 시장 규모 : 용도별
- 임상 시험에 사용되는 측방 유동 분석의 시장 규모
- 수의 진단에 사용되는 측방 유동 분석의 시장 규모
- 식품 안전 및 환경 시험에 사용되는 측방 유동 분석의 시장 규모
· 세계의 측방 유동 분석 시장 규모 : 기술별
- 샌드위치 분석 기술의 시장 규모
- 경쟁 분석 기술의 시장 규모
- 멀티플렉스 검출 분석 기술의 시장 규모
· 세계의 측방 유동 분석 시장 규모 : 샘플별
- 혈액 샘플의 시장 규모
- 소변 샘플의 시장 규모
- 타액 샘플의 시장 규모
· 세계의 측방 유동 분석 시장 규모 : 지역별
- 북미의 측방 유동 분석 시장 규모
- 유럽의 측방 유동 분석 시장 규모
- 아시아 태평양의 측방 유동 분석 시장 규모
- 중남미의 측방 유동 분석 시장 규모
- 중동 및 아프리카의 측방 유동 분석 시장 규모
· 경쟁 현황
· 기업 정보

■ 보고서 개요

“The global lateral flow assays market is projected to reach USD 22.6 billion by 2027 from USD 20.5 billion in 2022, at a CAGR of 2.0% during the forecast period.”
The growth of lateral flow assay market is due to the high prevalence of infectious diseases in many countries, growing demand for point-of-care testing, and rising use of home-based lateral flow assay devices whereas reluctance among doctors and patients to change existing diagnostic procedures and the low accuracy of lateral flow assays are restraining the market.

“Urine samples accounted for the third largest share of lateral flow assays market in 2021”
Based on sample type, the clinical testing lateral flow assays market is segmented into blood, urine, saliva, and other samples. Urine samples accounted for the third largest market share in 2021. The increasing use of urine samples in lateral flow tests for pregnancy, fertility testing, and drug of abuse testing.

“The Pharmaceutical & Biotechnology Companies segment is expected to witness the fastest growth during the forecast period”
Based on end users, the lateral flow assays market is segmented into hospitals & clinics, diagnostic laboratories, home care settings, pharmaceutical & biotechnology companies, and other end users. The pharmaceutical & biotechnology companies segment is expected to witness the fastest growth during the forecast period. This growth is owing to increasing adoption of lateral flow assay readers and kits & reagents for quantitative detection of sample in pharmaceutical & biotechnology companies.

“Asia-Pacific accounted for the second largest share of the lateral flow assays market in 2021”
The North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. In 2021, Asia-Pacific accounted for the second largest share of the lateral flow assays market, followed by Europe, Latin America, and the Middle East & Africa. However, the North America is a leading region in the lateral flow assay market. Being a high-growth market, many manufacturers are also extending their manufacturing bases in the Asia Pacific, which boasts low-cost manufacturing advantages and the availability of a skilled workforce, especially in China and India. These countries are also regarded as the most profitable manufacturing and R&D locations across the globe. The key factors hindering market growth in this region are a lack of awareness about the advantages of near-patient testing products due to low literacy rates, lack of reimbursements, challenges related to locational remoteness, and the reluctance of physicians to change existing practices.

A breakdown of the primary participants (supply-side) for the lateral flow assays market referred to for this report is provided below:
• By Company Type: Tier 1–35%, Tier 2–20%, and Tier 3–45%
• By Designation: C-level–45%, Director Level–25%, and Others–30%
• By Region: North America–36%, Europe–26%, Asia Pacific–21%, Latin America- 10%, and Middle East and Africa– 7%
Some of the key players in the Lateral flow assays market are Abbott Laboratories (US), F. Hoffman-La Roche AG (Switzerland), Danaher Corporation (US), Siemens AG (Germany), BD (US), bioMérieux SA (France), Thermo Fisher Scientific, Inc. (US), PerkinElmer Inc. (US), Hologic Inc. (US), QIAGEN N.V. (Netherlands), Quidel Corporation (US), and Merck KGaA (Germany).

Research Coverage:
The market study covers the lateral flow assays market across various segments. It aims at estimating the market size and the growth potential of this market across different segments by product type, application by technique, by sample type, end user, and region. The study also includes an in-depth competitive analysis of the key players in the market, along with their company profiles, key observations related to their product and business offerings, recent developments, and key market strategies.

Key Benefits of Buying the Report:
The report will help market leaders/new entrants in this market and provide information regarding the closest approximations of the lateral flow assays market and its segments. This report will help stakeholders understand the competitive landscape, gain insights to position their businesses better, and plan suitable go-to-market strategies. The report will also help stakeholders in understanding the pulse of the market and gaining information on key market drivers, restraints, opportunities, and challenges.

■ 보고서 목차

1 INTRODUCTION 32
1.1 STUDY OBJECTIVES 32
1.2 MARKET DEFINITION 32
1.2.1 INCLUSIONS AND EXCLUSIONS 33
1.3 MARKET SCOPE 34
1.3.1 MARKETS COVERED 34
FIGURE 1 LATERAL FLOW ASSAYS MARKET SEGMENTATION 34
FIGURE 2 REGIONAL SCOPE 35
1.3.2 YEARS CONSIDERED 35
1.4 CURRENCY CONSIDERED 35
TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD 36
1.5 STAKEHOLDERS 36
1.6 SUMMARY OF CHANGES 36
1.6.1 RECESSION IMPACT 37
2 RESEARCH METHODOLOGY 38
2.1 RESEARCH APPROACH 38
FIGURE 3 RESEARCH DESIGN 38
2.1.1 SECONDARY DATA 38
2.1.1.1 Key data from secondary sources 39
2.1.2 PRIMARY DATA 40
2.1.2.1 Primary sources 40
2.1.2.2 Key data from primary sources 41
2.1.2.3 Breakdown of primaries 41
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION 41
2.2 MARKET SIZE ESTIMATION 42
FIGURE 5 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS (2021) 43
FIGURE 6 SUPPLY-SIDE ANALYSIS: LATERAL FLOW ASSAYS MARKET (2021) 43
FIGURE 7 APPROACH 3: DEMAND-SIDE APPROACH, BASED ON MALARIA LATERAL FLOW TESTING MARKET SIZE (2021) 44
FIGURE 8 TOP-DOWN APPROACH 44
FIGURE 9 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2022–2027): IMPACT ON MARKET GROWTH AND CAGR 46
FIGURE 10 CAGR PROJECTIONS 46
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 47
FIGURE 11 DATA TRIANGULATION METHODOLOGY 48
2.4 KEY INDUSTRY INSIGHTS 49
2.5 LIMITATIONS 49
2.5.1 METHODOLOGY-RELATED LIMITATIONS 49
2.6 RISK ASSESSMENT 50
2.7 STUDY ASSUMPTIONS 50
2.8 RECESSION IMPACT 51
3 EXECUTIVE SUMMARY 52
FIGURE 12 LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2022 VS. 2027 (USD MILLION) 52
FIGURE 13 LATERAL FLOW ASSAY KITS AND REAGENTS MARKET, BY TECHNIQUE, 2022 VS. 2027 (USD MILLION) 53
FIGURE 14 LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2022 VS. 2027 (USD MILLION) 53
FIGURE 15 LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2022 VS. 2027 (USD MILLION) 54
FIGURE 16 LATERAL FLOW ASSAYS MARKET, BY END USER, 2022 VS. 2027 (USD MILLION) 55
FIGURE 17 GEOGRAPHIC SNAPSHOT OF LATERAL FLOW ASSAYS MARKET 56
4 PREMIUM INSIGHTS 57
4.1 LATERAL FLOW ASSAYS MARKET OVERVIEW 57
FIGURE 18 HIGH PREVALENCE OF INFECTIOUS DISEASES TO DRIVE MARKET 57
4.2 REGIONAL MIX: LATERAL FLOW ASSAYS MARKET 57
FIGURE 19 ASIA PACIFIC TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD 57
4.3 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET, BY APPLICATION AND COUNTRY (2021) 58
FIGURE 20 CLINICAL TESTING SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2021 58
4.4 LATERAL FLOW ASSAYS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 59
FIGURE 21 CHINA TO REGISTER HIGHEST GROWTH IN FORECAST PERIOD 59
4.5 LATERAL FLOW ASSAYS MARKET: DEVELOPING VS. DEVELOPED COUNTRIES 60
FIGURE 22 DEVELOPING COUNTRIES TO OFFER HIGH GROWTH OPPORTUNITIES IN FORECAST PERIOD 60
5 MARKET OVERVIEW 61
5.1 INTRODUCTION 61
5.2 MARKET DYNAMICS 61
FIGURE 23 LATERAL FLOW ASSAYS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 61
5.2.1 DRIVERS 62
5.2.1.1 High prevalence of infectious diseases 62
TABLE 2 PREVALENCE OF HIV WORLDWIDE (2017 VS. 2021) 62
5.2.1.2 Rapidly increasing geriatric population 63
FIGURE 24 GERIATRIC POPULATION, BY REGION, 2020 VS. 2050 (MILLION) 63
FIGURE 25 GERIATRIC POPULATION, BY REGION, 2022 VS. 2030 VS. 2050 (% OF TOTAL POPULATION) 64
5.2.1.3 Growing use of home-based lateral flow assay devices 64
5.2.1.4 Growing demand for point-of-care testing 65
5.2.1.5 Need for rapid diagnostic testing for COVID-19 65
5.2.2 RESTRAINTS 66
5.2.2.1 Inconsistent results of lateral flow assay tests 66
5.2.3 OPPORTUNITIES 66
5.2.3.1 Evolving applications of lateral flow assays 66
TABLE 3 LIST OF COMMERCIALLY AVAILABLE SALIVA LFA PRODUCTS 67
5.2.3.2 Rising demand for lateral flow assays in food & beverage industry 67
5.2.3.3 Omicron offers growth opportunities for players in lateral flow assays market 68
TABLE 4 EPIDEMIOLOGICAL UPDATE ON OMICRON VARIANT 68
TABLE 5 EXAMPLES OF LATERAL FLOW ASSAY KITS AVAILABLE FOR DETECTION OF OMICRON 68
5.2.4 CHALLENGES 69
5.2.4.1 Limited reimbursements for lateral flow assay products 69
5.2.4.2 Difficulties in procuring quality raw materials for development of lateral flow assay tests 70
5.3 COVID-19 IMPACT ASSESSMENT ON ECONOMIC SCENARIO 70
5.4 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 70
FIGURE 26 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 71
5.5 AVERAGE SELLING PRICE TREND 71
5.5.1 AVERAGE SELLING PRICES OF KEY PLAYERS, BY APPLICATION 71
TABLE 6 AVERAGE SELLING PRICE OF LATERAL FLOW ASSAYS (KITS AND REAGENTS) 71
5.5.2 AVERAGE SELLING PRICE TRENDS 72
TABLE 7 AVERAGE SELLING PRICE OF LATERAL FLOW ANALYZERS, BY REGION, 2020 VS. 2021 72
5.6 ECOSYSTEM MARKET MAP 72
FIGURE 27 LATERAL FLOW ASSAYS MARKET: ECOSYSTEM ANALYSIS (2021) 73
5.7 PATENT ANALYSIS 74
5.7.1 PATENT PUBLICATION TRENDS FOR LATERAL FLOW ASSAYS 74
FIGURE 28 GLOBAL PATENT PUBLICATION TRENDS IN LATERAL FLOW ASSAYS MARKET, 2016–2022 74
5.7.2 TOP APPLICANTS (COMPANIES) OF LATERAL FLOW ASSAY PATENTS 75
FIGURE 29 TOP COMPANIES THAT APPLIED FOR LATERAL FLOW ASSAY PATENTS, 2016–2022 75
5.7.3 JURISDICTION ANALYSIS: TOP APPLICANTS (COUNTRIES) FOR PATENTS IN LATERAL FLOW ASSAYS MARKET 75
FIGURE 30 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR LATERAL FLOW ASSAY PATENTS, 2016–2022 75
5.8 VALUE CHAIN ANALYSIS 76
FIGURE 31 LATERAL FLOW ASSAYS MARKET: VALUE CHAIN ANALYSIS (2021) 76
5.9 TECHNOLOGY ANALYSIS 76
5.9.1 KEY TECHNOLOGY: LATERAL FLOW ASSAYS 76
5.9.2 ADJACENT TECHNOLOGY: ENZYME-LINKED IMMUNOSORBENT ASSAYS 77
5.10 CASE STUDY ANALYSIS 77
5.11 REGULATORY ANALYSIS 78
5.11.1 REGULATORY LANDSCAPE 78
5.11.1.1 North America 78
5.11.1.2 Europe 78
5.11.1.3 Asia 79
5.11.1.3.1 India 79
5.11.1.3.2 China 79
5.11.1.3.3 Japan 79
5.11.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 80
TABLE 8 REGULATORY STANDARDS/APPROVALS REQUIRED FOR LATERAL FLOW IMMUNOASSAY BY REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 80
5.12 PORTER’S FIVE FORCES ANALYSIS 80
TABLE 9 LATERAL FLOW ASSAYS MARKET: PORTER’S FIVE FORCES ANALYSIS 80
5.12.1 THREAT OF NEW ENTRANTS 81
5.12.2 THREAT OF SUBSTITUTES 81
5.12.3 BARGAINING POWER OF SUPPLIERS 82
5.12.4 BARGAINING POWER OF BUYERS 82
5.12.5 INTENSITY OF COMPETITIVE RIVALRY 82
5.13 ADJACENT MARKET ANALYSIS 82
5.14 KEY CONFERENCES AND EVENTS DURING 2023–2024 83
TABLE 10 LATERAL FLOW ASSAYS MARKET: DETAILED LIST OF CONFERENCES & EVENTS 83
5.15 KEY STAKEHOLDERS AND BUYING CRITERIA 84
5.15.1 KEY STAKEHOLDERS IN BUYING PROCESS 84
FIGURE 32 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE APPLICATIONS 84
TABLE 11 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE APPLICATIONS 84
5.15.2 BUYING CRITERIA 84
FIGURE 33 KEY BUYING CRITERIA FOR TOP THREE APPLICATIONS 84
5.16 TRADE ANALYSIS 85
5.17 INDUSTRY TRENDS 85
5.17.1 DETECTION OF HIV WITH LATERAL FLOW ASSAYS 85
TABLE 12 US: HIV PREVALENCE RATE, 2016–2020 85
5.17.2 INCREASING ADOPTION OF QUANTITATIVE LATERAL FLOW ASSAYS DUE TO AVAILABILITY OF LFA READERS 86
5.18 IMPACT OF INFLATION AND RECESSION ON LATERAL FLOW ASSAYS MARKET 86

6 LATERAL FLOW ASSAYS MARKET, BY PRODUCT 88
6.1 INTRODUCTION 89
TABLE 13 LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 89
6.2 KITS AND REAGENTS 89
6.2.1 INCREASING DEMAND FOR POC TESTING TO DRIVE MARKET 89
TABLE 14 LATERAL FLOW KITS AND REAGENTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 90
6.3 LATERAL FLOW READERS 90
TABLE 15 EXAMPLES OF LATERAL FLOW READERS AVAILABLE IN MARKET 91
TABLE 16 LATERAL FLOW ASSAY KITS AND REAGENTS WITH AND WITHOUT ANALYZERS 92
TABLE 17 LATERAL FLOW READERS MARKET, BY TYPE, 2020–2027 (USD MILLION) 93
TABLE 18 LATERAL FLOW READERS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 93
TABLE 19 LATERAL FLOW READERS MARKET, BY END USER, 2020–2027 (USD MILLION) 93
TABLE 20 LATERAL FLOW READERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 94
6.3.1 DIGITAL/HANDHELD READERS 94
6.3.1.1 Technological advancements and high accuracy—major factors driving market 94
TABLE 21 DIGITAL/HANDHELD LATERAL FLOW READERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 95
TABLE 22 DIGITAL/HANDHELD LATERAL FLOW READERS MARKET, BY REGION, 2020–2027 (THOUSAND UNITS) 96
6.3.2 BENCHTOP READERS 96
6.3.2.1 Lower diagnosis cost per patient to drive adoption 96
TABLE 23 BENCHTOP LATERAL FLOW READERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 97
TABLE 24 BENCHTOP LATERAL FLOW READERS MARKET, BY REGION, 2020–2027 (THOUSAND UNITS) 97
6.4 INSIGHTS ON DISPOSABLE AND REUSABLE LATERAL FLOW READERS 98
6.5 LATERAL FLOW READERS MARKET FOR CLINICAL DIAGNOSTIC APPLICATIONS, BY TYPE 98
6.5.1 PRODUCT PORTFOLIO ANALYSIS OF LATERAL FLOW READERS FOR CLINICAL DIAGNOSTIC APPLICATIONS 98
TABLE 25 PRODUCT PORTFOLIO ANALYSIS OF LATERAL FLOW READERS FOR CLINICAL DIAGNOSTIC APPLICATIONS 98
FIGURE 34 PRODUCT PORTFOLIO ANALYSIS OF LATERAL FLOW READERS FOR CLINICAL DIAGNOSTICS (2021) 100
7 LATERAL FLOW ASSAYS MARKET, BY APPLICATION 101
7.1 INTRODUCTION 102
TABLE 26 LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 102
7.2 CLINICAL TESTING 102
TABLE 27 LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY TYPE, 2020–2027 (USD MILLION) 103
TABLE 28 LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 104
7.2.1 INFECTIOUS DISEASE TESTING 104
TABLE 29 LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY TYPE, 2020–2027 (USD MILLION) 105
TABLE 30 LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 106
7.2.1.1 Mosquito-borne diseases 106
7.2.1.1.1 Increasing incidence of dengue to support market growth 106
TABLE 31 DENGUE TESTING PRODUCTS AVAILABLE IN MARKET 107
TABLE 32 LATERAL FLOW ASSAYS MARKET FOR MOSQUITO-BORNE DISEASES, BY COUNTRY, 2020–2027 (USD MILLION) 108
7.2.1.2 COVID-19 109
7.2.1.2.1 COVID-19 pandemic resulted in adoption of rapid lateral flow tests 109
TABLE 33 LATERAL FLOW ASSAY TESTS FOR COVID-19 (ANTIGEN AND ANTIBODY) 109
TABLE 34 LATERAL FLOW ASSAYS MARKET FOR COVID-19, BY COUNTRY, 2020–2027 (USD MILLION) 110
7.2.1.3 Influenza 111
7.2.1.3.1 Growing prevalence of influenza to support market growth 111
TABLE 35 LATERAL FLOW ASSAYS MARKET FOR INFLUENZA, BY COUNTRY, 2020–2027 (USD MILLION) 112
7.2.1.4 Sexually transmitted infections 112
TABLE 36 LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2020–2027 (USD MILLION) 113
TABLE 37 LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY COUNTRY, 2020–2027 (USD MILLION) 114
7.2.1.4.1 HIV 114
7.2.1.4.1.1 Growing awareness of HIV POC testing to drive market 114
TABLE 38 LATERAL FLOW ASSAYS MARKET FOR HIV, BY COUNTRY, 2020–2027 (USD MILLION) 116
7.2.1.4.2 HPV 116
7.2.1.4.2.1 Rising adoption of HPV testing to drive market during forecast period 116
TABLE 39 LATERAL FLOW ASSAYS MARKET FOR HPV, BY COUNTRY, 2020–2027 (USD MILLION) 117
7.2.1.4.3 Chlamydia 117
7.2.1.4.3.1 Growing incidence of chlamydia and rising awareness among patients to drive market 117
TABLE 40 LATERAL FLOW ASSAYS MARKET FOR CHLAMYDIA, BY COUNTRY, 2020–2027 (USD MILLION) 118
7.2.1.4.4 Gonorrhea 118
7.2.1.4.4.1 Rising incidence of gonorrhea and increased funding for R&D to support market growth 118
TABLE 41 LATERAL FLOW ASSAYS MARKET FOR GONORRHEA, BY COUNTRY, 2020–2027 (USD MILLION) 119
7.2.1.4.5 Syphilis 120
7.2.1.4.5.1 Growing adoption of novel technologies to support market growth 120
TABLE 42 LATERAL FLOW ASSAYS MARKET FOR SYPHILIS, BY COUNTRY, 2020–2027 (USD MILLION) 121
7.2.1.4.6 Other sexually transmitted infections 121
TABLE 43 LATERAL FLOW ASSAYS MARKET FOR OTHER SEXUALLY TRANSMITTED INFECTIONS, BY COUNTRY, 2020–2027 (USD MILLION) 122
7.2.1.5 Hepatitis 122
7.2.1.5.1 Nucleic acid hybridization-based lateral flow assays hold great potential in hepatitis testing market 122
TABLE 44 LATERAL FLOW ASSAYS MARKET FOR HEPATITIS, BY COUNTRY, 2020–2027 (USD MILLION) 123
7.2.1.6 Tuberculosis 123
7.2.1.6.1 Rising prevalence and growing focus on early diagnosis and treatment to drive market 123
TABLE 45 LATERAL FLOW ASSAYS MARKET FOR TUBERCULOSIS, BY COUNTRY, 2020–2027 (USD MILLION) 124
7.2.1.7 Other infectious diseases 124
TABLE 46 LATERAL FLOW ASSAYS MARKET FOR OTHER INFECTIOUS DISEASES, BY COUNTRY, 2020–2027 (USD MILLION) 125
7.2.2 CARDIAC MARKER TESTING 126
TABLE 47 LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2020–2027 (USD MILLION) 126
TABLE 48 LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 127
7.2.2.1 Troponin I and T 127
7.2.2.1.1 Introduction of high-sensitivity troponin assays to drive market 127
TABLE 49 LATERAL FLOW ASSAYS MARKET FOR TROPONIN I AND T TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 128
7.2.2.2 CK-MB 128
7.2.2.2.1 Growing applications of lateral flow tests in acute myocardial injuries to drive market 128
TABLE 50 LATERAL FLOW ASSAYS MARKET FOR CK-MB TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 129
7.2.2.3 BNP and NT-proBNP 129
7.2.2.3.1 Increasing demand for cardiac biomarker tests to detect heart stress and damage to propel adoption 129
TABLE 51 LATERAL FLOW ASSAYS MARKET FOR BNP AND NT-PROBNP TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 130
7.2.2.4 Myoglobin 130
7.2.2.4.1 Availability of new high-sensitivity cardiac troponin assays to restrict market growth 130
TABLE 52 LATERAL FLOW ASSAYS MARKET FOR MYOGLOBIN TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 131
7.2.2.5 D-dimer 131
7.2.2.5.1 Rising incidence of cardiovascular diseases to drive market for D-dimer tests 131
TABLE 53 LATERAL FLOW ASSAYS MARKET FOR D-DIMER TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 132
7.2.2.6 Other cardiac markers 132
TABLE 54 LATERAL FLOW ASSAYS MARKET FOR OTHER CARDIAC MARKER TESTS, BY COUNTRY, 2020–2027 (USD MILLION) 133
7.2.3 PREGNANCY AND FERTILITY TESTING 133
TABLE 55 LATERAL FLOW ASSAYS MARKET FOR PREGNANCY AND FERTILITY TESTING, BY TYPE, 2020–2027 (USD MILLION) 134
TABLE 56 LATERAL FLOW ASSAYS MARKET FOR PREGNANCY AND FERTILITY TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 135
7.2.3.1 Pregnancy testing 135
7.2.3.1.1 Most common application area for lateral flow assays 135
TABLE 57 LATERAL FLOW ASSAYS MARKET FOR PREGNANCY TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 136
7.2.3.2 Fertility testing 136
7.2.3.2.1 Rising infertility rates to drive demand for POC fertility testing kits 136
TABLE 58 LATERAL FLOW ASSAYS MARKET FOR FERTILITY TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 137
7.2.4 CHOLESTEROL/LIPID TESTING 137
7.2.4.1 Growing prevalence of obesity and CVD to drive market 137
TABLE 59 LATERAL FLOW ASSAYS MARKET FOR CHOLESTEROL/LIPID TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 138
7.2.5 DRUGS-OF-ABUSE TESTING 138
7.2.5.1 Technological advancements and growing focus on workplace drug testing to drive market 138
TABLE 60 LATERAL FLOW ASSAYS MARKET FOR DRUGS-OF-ABUSE TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 139
7.2.6 OTHER CLINICAL TESTS 139
TABLE 61 LATERAL FLOW ASSAYS MARKET FOR OTHER CLINICAL TESTS, BY COUNTRY, 2020–2027 (USD MILLION) 140
7.3 VETERINARY DIAGNOSTICS 140
7.3.1 INFECTIOUS DISEASE OUTBREAKS, PARTICULARLY IN LARGE LIVESTOCK ANIMALS, TO DRIVE MARKET 140
TABLE 62 LATERAL FLOW ASSAYS MARKET FOR VETERINARY DIAGNOSTICS, BY COUNTRY, 2020–2027 (USD MILLION) 141
7.4 FOOD SAFETY AND ENVIRONMENTAL TESTING 142
7.4.1 HIGH SENSITIVITY AND EASE OF USE SUPPORTING MARKET GROWTH 142
TABLE 63 LATERAL FLOW ASSAYS MARKET FOR FOOD SAFETY AND ENVIRONMENTAL TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 143
7.5 DRUG DEVELOPMENT AND QUALITY TESTING 143
7.5.1 INCREASING FOCUS ON PRODUCT SAFETY AND QUALITY ASSURANCE TO DRIVE MARKET 143
TABLE 64 LATERAL FLOW ASSAYS MARKET FOR DRUG DEVELOPMENT AND QUALITY TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 144

8 LATERAL FLOW ASSAY KITS AND REAGENTS MARKET, BY TECHNIQUE 145
8.1 INTRODUCTION 146
TABLE 65 LATERAL FLOW ASSAY KITS AND REAGENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 146
TABLE 66 LATERAL FLOW ASSAY KITS AND REAGENTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 147
8.2 SANDWICH ASSAYS 147
8.2.1 WIDE APPLICATIONS IN CLINICAL TESTING TO SUPPORT MARKET GROWTH 147
TABLE 67 LATERAL FLOW SANDWICH ASSAYS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 148
8.3 COMPETITIVE ASSAYS 149
8.3.1 REDUCED SELECTIVITY AND SENSITIVITY IN RELATION TO SANDWICH ASSAYS TO HAMPER GROWTH 149
TABLE 68 LATERAL FLOW COMPETITIVE ASSAYS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 150
8.4 MULTIPLEX DETECTION ASSAYS 150
8.4.1 INCREASING ADOPTION OF MULTI-ANALYTE ASSAYS AMONG CLINICIANS TO DRIVE MARKET 150
TABLE 69 LATERAL FLOW MULTIPLEX DETECTION ASSAYS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 151
9 LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE 152
9.1 INTRODUCTION 153
TABLE 70 LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2020–2027 (USD MILLION) 153
9.2 BLOOD SAMPLES 153
9.2.1 INCREASING USE OF BLOOD SAMPLES IN INFECTIOUS DISEASE TESTING TO DRIVE MARKET 153
TABLE 71 LATERAL FLOW ASSAYS MARKET FOR BLOOD SAMPLES, BY COUNTRY, 2020–2027 (USD MILLION) 154
9.3 URINE SAMPLES 154
9.3.1 GROWING USE OF URINE SAMPLES IN PREGNANCY AND DRUGS-OF-ABUSE TESTING TO DRIVE MARKET 154
TABLE 72 LATERAL FLOW ASSAYS MARKET FOR URINE SAMPLES, BY COUNTRY, 2020–2027 (USD MILLION) 155
9.4 SALIVA SAMPLES 155
9.4.1 EASY AND LOW-COST COLLECTION, TRANSPORT, AND ANALYSIS OF SALIVA SAMPLES TO SUPPORT ADOPTION 155
TABLE 73 LATERAL FLOW ASSAYS MARKET FOR SALIVA SAMPLES, BY COUNTRY, 2020–2027 (USD MILLION) 156
9.5 OTHER SAMPLES 157
TABLE 74 LATERAL FLOW ASSAYS MARKET FOR OTHER SAMPLES, BY COUNTRY, 2020–2027 (USD MILLION) 157

10 LATERAL FLOW ASSAYS MARKET, BY END USER 158
10.1 INTRODUCTION 159
TABLE 75 LATERAL FLOW ASSAYS MARKET, BY END USER, 2020–2027 (USD MILLION) 159
10.2 HOSPITALS AND CLINICS 159
10.2.1 INCREASING USE OF POC TESTS TO DRIVE MARKET 159
TABLE 76 LATERAL FLOW ASSAYS MARKET FOR HOSPITALS AND CLINICS, BY COUNTRY, 2020–2027 (USD MILLION) 160
10.3 HOME CARE SETTINGS 160
10.3.1 GROWING ACCEPTANCE OF REMOTE MONITORING TO PROPEL MARKET 160
TABLE 77 LATERAL FLOW ASSAYS MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2020–2027 (USD MILLION) 161
10.4 DIAGNOSTIC LABORATORIES 162
10.4.1 HIGH PREFERENCE FOR LABORATORY TESTING TO TEST URINE AND BLOOD SAMPLES TO SUPPORT MARKET GROWTH 162
TABLE 78 LATERAL FLOW ASSAYS MARKET FOR DIAGNOSTIC LABORATORIES, BY COUNTRY, 2020–2027 (USD MILLION) 163
10.5 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES 163
10.5.1 INCREASING FOCUS ON PRODUCT SAFETY TO DRIVE ADOPTION OF LATERAL FLOW ASSAYS 163
TABLE 79 LATERAL FLOW ASSAYS MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2020–2027 (USD MILLION) 164
10.6 OTHER END USERS 164
TABLE 80 LATERAL FLOW ASSAYS MARKET FOR OTHER END USERS, BY COUNTRY, 2020–2027 (USD MILLION) 165
11 LATERAL FLOW ASSAYS MARKET, BY REGION 166
11.1 INTRODUCTION 167
FIGURE 35 CHINA TO WITNESS HIGHEST GROWTH DURING FORECAST PERIOD 167
TABLE 81 LATERAL FLOW ASSAYS MARKET, BY REGION, 2020–2027 (USD MILLION) 168
11.2 NORTH AMERICA 168
TABLE 82 NORTH AMERICA: MACROECONOMIC INDICATORS 169
FIGURE 36 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET SNAPSHOT 169
TABLE 83 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 170
TABLE 84 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 170
TABLE 85 NORTH AMERICA: LATERAL FLOW READERS MARKET, BY TYPE, 2020–2027 (USD MILLION) 170
TABLE 86 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 171
TABLE 87 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 171
TABLE 88 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY TYPE, 2020–2027 (USD MILLION) 172
TABLE 89 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2020–2027 (USD MILLION) 172
TABLE 90 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2020–2027 (USD MILLION) 173
TABLE 91 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY AND FERTILITY TESTING, BY TYPE, 2020–2027 (USD MILLION) 173
TABLE 92 NORTH AMERICA: LATERAL FLOW ASSAY KITS AND REAGENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 173
TABLE 93 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2020–2027 (USD MILLION) 174
TABLE 94 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET, BY END USER, 2020–2027 (USD MILLION) 174
11.2.1 US 174
11.2.1.1 Largest market for lateral flow assays 174
TABLE 95 US: MACROECONOMIC INDICATORS 175
TABLE 96 US: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 175
TABLE 97 US: LATERAL FLOW READERS MARKET, BY TYPE, 2020–2027 (USD MILLION) 176
TABLE 98 US: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 176
TABLE 99 US: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 176
TABLE 100 US: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY TYPE, 2020–2027 (USD MILLION) 177
TABLE 101 US: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2020–2027 (USD MILLION) 177
TABLE 102 US: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2020–2027 (USD MILLION) 178
TABLE 103 US: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY AND FERTILITY TESTING, BY TYPE, 2020–2027 (USD MILLION) 178
TABLE 104 US: LATERAL FLOW ASSAY KITS AND REAGENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 178
TABLE 105 US: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2020–2027 (USD MILLION) 179
TABLE 106 US: LATERAL FLOW ASSAYS MARKET, BY END USER, 2020–2027 USD MILLION) 179
11.2.2 CANADA 179
11.2.2.1 Availability of research funding and implementation of favorable government initiatives to drive market 179
TABLE 107 CANADA: MACROECONOMIC INDICATORS 180
TABLE 108 CANADA: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 180
TABLE 109 CANADA: LATERAL FLOW READERS MARKET, BY TYPE, 2020–2027 (USD MILLION) 181
TABLE 110 CANADA: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 181
TABLE 111 CANADA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 182
TABLE 112 CANADA: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY TYPE, 2020–2027 (USD MILLION) 182
TABLE 113 CANADA: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2020–2027 (USD MILLION) 183
TABLE 114 CANADA: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2020–2027 (USD MILLION) 183
TABLE 115 CANADA: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY AND FERTILITY TESTING, BY TYPE, 2020–2027 (USD MILLION) 184
TABLE 116 CANADA: LATERAL FLOW ASSAY KITS AND REAGENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 184
TABLE 117 CANADA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2020–2027 (USD MILLION) 184
TABLE 118 CANADA: LATERAL FLOW ASSAYS MARKET, BY END USER, 2020–2027 USD MILLION) 185
11.2.3 RECESSION IMPACT 185
11.3 EUROPE 186
TABLE 119 EUROPE: LATERAL FLOW ASSAYS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 186
TABLE 120 EUROPE: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 186
TABLE 121 EUROPE: LATERAL FLOW READERS MARKET, BY TYPE, 2020–2027 (USD MILLION) 187
TABLE 122 EUROPE: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 187
TABLE 123 EUROPE: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 187
TABLE 124 EUROPE: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY TYPE, 2020–2027 (USD MILLION) 188
TABLE 125 EUROPE: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2020–2027 (USD MILLION) 188
TABLE 126 EUROPE: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2020–2027 (USD MILLION) 189
TABLE 127 EUROPE: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY AND FERTILITY TESTING, BY TYPE, 2020–2027 (USD MILLION) 189
TABLE 128 EUROPE: LATERAL FLOW ASSAY KITS AND REAGENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 189
TABLE 129 EUROPE: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2020–2027 (USD MILLION) 190
TABLE 130 EUROPE: LATERAL FLOW ASSAYS MARKET, BY END USER, 2020–2027 (USD MILLION) 190
11.3.1 GERMANY 190
11.3.1.1 Growing number of POC diagnostic centers to drive demand for lateral flow assays 190
TABLE 131 GERMANY: MACROECONOMIC INDICATORS 191
TABLE 132 GERMANY: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 191
TABLE 133 GERMANY: LATERAL FLOW READERS MARKET, BY TYPE, 2020–2027 (USD MILLION) 191
TABLE 134 GERMANY: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 192
TABLE 135 GERMANY: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 192
TABLE 136 GERMANY: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY TYPE, 2020–2027 (USD MILLION) 193
TABLE 137 GERMANY: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2020–2027 (USD MILLION) 193
TABLE 138 GERMANY: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2020–2027 (USD MILLION) 194
TABLE 139 GERMANY: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY AND FERTILITY TESTING, BY TYPE, 2020–2027 (USD MILLION) 194
TABLE 140 GERMANY: LATERAL FLOW ASSAY KITS AND REAGENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 194
TABLE 141 GERMANY: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2020–2027 (USD MILLION) 195
TABLE 142 GERMANY: LATERAL FLOW ASSAYS MARKET, BY END USER, 2020–2027 (USD MILLION) 195
11.3.2 FRANCE 196
11.3.2.1 High prevalence of age-related chronic and infectious diseases to drive market 196
TABLE 143 FRANCE: MACROECONOMIC INDICATORS 196
TABLE 144 FRANCE: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 196
TABLE 145 FRANCE: LATERAL FLOW READERS MARKET, BY TYPE, 2020–2027 (USD MILLION) 197
TABLE 146 FRANCE: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 197
TABLE 147 FRANCE: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 198
TABLE 148 FRANCE: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY TYPE, 2020–2027 (USD MILLION) 198
TABLE 149 FRANCE: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2020–2027 (USD MILLION) 199
TABLE 150 FRANCE: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2020–2027 (USD MILLION) 199
TABLE 151 FRANCE: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY AND FERTILITY TESTING, BY TYPE, 2020–2027 (USD MILLION) 200
TABLE 152 FRANCE: LATERAL FLOW ASSAY KITS AND REAGENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 200
TABLE 153 FRANCE: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2020–2027 (USD MILLION) 200
TABLE 154 FRANCE: LATERAL FLOW ASSAYS MARKET, BY END USER, 2020–2027 (USD MILLION) 201
11.3.3 UK 201
11.3.3.1 Rising prevalence of obesity to propel market 201
TABLE 155 UK: MACROECONOMIC INDICATORS 202
TABLE 156 UK: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 202
TABLE 157 UK: LATERAL FLOW READERS MARKET, BY TYPE, 2020–2027 (USD MILLION) 202
TABLE 158 UK: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 203
TABLE 159 UK: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 203
TABLE 160 UK: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY TYPE, 2020–2027 (USD MILLION) 204
TABLE 161 UK: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2020–2027 (USD MILLION) 204
TABLE 162 UK: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2020–2027 (USD MILLION) 205
TABLE 163 UK: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY AND FERTILITY TESTING, BY TYPE, 2020–2027 (USD MILLION) 205
TABLE 164 UK: LATERAL FLOW ASSAY KITS AND REAGENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 205
TABLE 165 UK: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2020–2027 (USD MILLION) 206
TABLE 166 UK: LATERAL FLOW ASSAYS MARKET, BY END USER, 2020–2027 (USD MILLION) 206
11.3.4 ITALY 206
11.3.4.1 Growing initiatives toward decentralization of medical services to support market growth 206
TABLE 167 ITALY: MACROECONOMIC INDICATORS 207
TABLE 168 ITALY: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 207
TABLE 169 ITALY: LATERAL FLOW READERS MARKET, BY TYPE, 2020–2027 (USD MILLION) 207
TABLE 170 ITALY: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 208
TABLE 171 ITALY: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 208
TABLE 172 ITALY: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY TYPE, 2020–2027 (USD MILLION) 209
TABLE 173 ITALY: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2020–2027 (USD MILLION) 209
TABLE 174 ITALY: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2020–2027 (USD MILLION) 210
TABLE 175 ITALY: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY AND FERTILITY TESTING, BY TYPE, 2020–2027 (USD MILLION) 210
TABLE 176 ITALY: LATERAL FLOW ASSAY KITS AND REAGENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 210
TABLE 177 ITALY: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2020–2027 (USD MILLION) 211
TABLE 178 ITALY: LATERAL FLOW ASSAYS MARKET, BY END USER, 2020–2027 (USD MILLION) 211
11.3.5 SPAIN 211
11.3.5.1 Increasing focus of international organizations and domestic players on development of POC products to aid market growth 211
TABLE 179 SPAIN: MACROECONOMIC INDICATORS 212
TABLE 180 SPAIN: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 212
TABLE 181 SPAIN: LATERAL FLOW READERS MARKET, BY TYPE, 2020–2027 (USD MILLION) 212
TABLE 182 SPAIN: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 213
TABLE 183 SPAIN: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 213
TABLE 184 SPAIN: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY TYPE, 2020–2027 (USD MILLION) 214
TABLE 185 SPAIN: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2020–2027 (USD MILLION) 214
TABLE 186 SPAIN: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2020–2027 (USD MILLION) 215
TABLE 187 SPAIN: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY AND FERTILITY TESTING, BY TYPE, 2020–2027 (USD MILLION) 215
TABLE 188 SPAIN: LATERAL FLOW ASSAY KITS AND REAGENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 215
TABLE 189 SPAIN: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2020–2027 (USD MILLION) 216
TABLE 190 SPAIN: LATERAL FLOW ASSAYS MARKET, BY END USER, 2020–2027 (USD MILLION) 216
11.3.6 REST OF EUROPE 216
TABLE 191 REST OF EUROPE: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 217
TABLE 192 REST OF EUROPE: LATERAL FLOW READERS MARKET, BY TYPE, 2020–2027 (USD MILLION) 217
TABLE 193 REST OF EUROPE: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 217
TABLE 194 REST OF EUROPE: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 218
TABLE 195 REST OF EUROPE: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY TYPE, 2020–2027 (USD MILLION) 218
TABLE 196 REST OF EUROPE: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2020–2027 (USD MILLION) 219
TABLE 197 REST OF EUROPE: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2020–2027 (USD MILLION) 219
TABLE 198 REST OF EUROPE: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY AND FERTILITY TESTING, BY TYPE, 2020–2027 (USD MILLION) 220
TABLE 199 REST OF EUROPE: LATERAL FLOW ASSAY KITS AND REAGENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 220
TABLE 200 REST OF EUROPE: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2020–2027 (USD MILLION) 220
TABLE 201 REST OF EUROPE: LATERAL FLOW ASSAYS MARKET, BY END USER, 2020–2027 (USD MILLION) 221
11.3.7 RECESSION IMPACT 221

11.4 ASIA PACIFIC 221
FIGURE 37 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET SNAPSHOT 222
TABLE 202 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 223
TABLE 203 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 223
TABLE 204 ASIA PACIFIC: LATERAL FLOW READERS MARKET, BY TYPE, 2020–2027 (USD MILLION) 223
TABLE 205 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 224
TABLE 206 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 224
TABLE 207 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY TYPE, 2020–2027 (USD MILLION) 225
TABLE 208 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2020–2027 (USD MILLION) 225
TABLE 209 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2020–2027 (USD MILLION) 226
TABLE 210 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY AND FERTILITY TESTING, BY TYPE, 2020–2027 (USD MILLION) 226
TABLE 211 ASIA PACIFIC: LATERAL FLOW ASSAY KITS AND REAGENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 226
TABLE 212 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2020–2027 (USD MILLION) 227
TABLE 213 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET, BY END USER, 2020–2027 (USD MILLION) 227
11.4.1 CHINA 227
11.4.1.1 Growing adoption of lateral flow assays in veterinary diagnostics and drug development to drive market 227
TABLE 214 CHINA: MACROECONOMIC INDICATORS 228
TABLE 215 CHINA: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 228
TABLE 216 CHINA: LATERAL FLOW READERS MARKET, BY TYPE, 2020–2027 (USD MILLION) 229
TABLE 217 CHINA: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 229
TABLE 218 CHINA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 229
TABLE 219 CHINA: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY TYPE, 2020–2027 (USD MILLION) 230
TABLE 220 CHINA: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2020–2027 (USD MILLION) 230
TABLE 221 CHINA: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2020–2027 (USD MILLION) 231
TABLE 222 CHINA: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY AND FERTILITY TESTING, BY TYPE, 2020–2027 (USD MILLION) 231
TABLE 223 CHINA: LATERAL FLOW ASSAY KITS AND REAGENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 231
TABLE 224 CHINA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2020–2027 (USD MILLION) 232
TABLE 225 CHINA: LATERAL FLOW ASSAYS MARKET, BY END USER, 2020–2027 (USD MILLION) 232
11.4.2 JAPAN 232
11.4.2.1 Increasing prevalence of age-related illnesses to drive market 232
TABLE 226 JAPAN: MACROECONOMIC INDICATORS 233
TABLE 227 JAPAN: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 233
TABLE 228 JAPAN: LATERAL FLOW READERS MARKET, BY TYPE, 2020–2027 (USD MILLION) 234
TABLE 229 JAPAN: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 234
TABLE 230 JAPAN: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 234
TABLE 231 JAPAN: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY TYPE, 2020–2027 (USD MILLION) 235
TABLE 232 JAPAN: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2020–2027 (USD MILLION) 235
TABLE 233 JAPAN: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2020–2027 (USD MILLION) 236
TABLE 234 JAPAN: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY AND FERTILITY TESTING, BY TYPE, 2020–2027 (USD MILLION) 236
TABLE 235 JAPAN: LATERAL FLOW ASSAY KITS AND REAGENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 236
TABLE 236 JAPAN: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2020–2027 (USD MILLION) 237
TABLE 237 JAPAN: LATERAL FLOW ASSAYS MARKET, BY END USER, 2020–2027 (USD MILLION) 237
11.4.3 INDIA 237
11.4.3.1 Growing healthcare concerns and rising income levels to propel market 237
TABLE 238 INDIA: MACROECONOMIC INDICATORS 238
TABLE 239 INDIA: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 238
TABLE 240 INDIA: LATERAL FLOW READERS MARKET, BY TYPE, 2020–2027 (USD MILLION) 238
TABLE 241 INDIA: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 239
TABLE 242 INDIA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 239
TABLE 243 INDIA: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY TYPE, 2020–2027 (USD MILLION) 240
TABLE 244 INDIA: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2020–2027 (USD MILLION) 240
TABLE 245 INDIA: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2020–2027 (USD MILLION) 241
TABLE 246 INDIA: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY AND FERTILITY TESTING, BY TYPE, 2020–2027 (USD MILLION) 241
TABLE 247 INDIA: LATERAL FLOW ASSAY KITS AND REAGENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 241
TABLE 248 INDIA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2020–2027 (USD MILLION) 242
TABLE 249 INDIA: LATERAL FLOW ASSAYS MARKET, BY END USER, 2020–2027 (USD MILLION) 242
11.4.4 AUSTRALIA 242
11.4.4.1 Increasing prevalence of infectious diseases, especially influenza, to drive market 242
TABLE 250 AUSTRALIA: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 243
TABLE 251 AUSTRALIA: LATERAL FLOW READERS MARKET, BY TYPE, 2020–2027 (USD MILLION) 243
TABLE 252 AUSTRALIA: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 243
TABLE 253 AUSTRALIA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 244
TABLE 254 AUSTRALIA: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY TYPE, 2020–2027 (USD MILLION) 244
TABLE 255 AUSTRALIA: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2020–2027 (USD MILLION) 245
TABLE 256 AUSTRALIA: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2020–2027 (USD MILLION) 245
TABLE 257 AUSTRALIA: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY AND FERTILITY TESTING, BY TYPE, 2020–2027 (USD MILLION) 246
TABLE 258 AUSTRALIA: LATERAL FLOW ASSAY KITS AND REAGENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 246
TABLE 259 AUSTRALIA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2020–2027 (USD MILLION) 246
TABLE 260 AUSTRALIA: LATERAL FLOW ASSAYS MARKET, BY END USER, 2020–2027 (USD MILLION) 247
11.4.5 REST OF ASIA PACIFIC 247
TABLE 261 REST OF ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 247
TABLE 262 REST OF ASIA PACIFIC: LATERAL FLOW READERS MARKET, BY TYPE, 2020–2027 (USD MILLION) 248
TABLE 263 REST OF ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 248
TABLE 264 REST OF ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 249
TABLE 265 REST OF ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY TYPE, 2020–2027 (USD MILLION) 249
TABLE 266 REST OF ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2020–2027 (USD MILLION) 250
TABLE 267 REST OF ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2020–2027 (USD MILLION) 250
TABLE 268 REST OF ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY AND FERTILITY TESTING, BY TYPE, 2020–2027 (USD MILLION) 251
TABLE 269 REST OF ASIA PACIFIC: LATERAL FLOW ASSAY KITS AND REAGENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 251
TABLE 270 REST OF ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2020–2027 (USD MILLION) 251
TABLE 271 REST OF ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET, BY END USER, 2020–2027 (USD MILLION) 252
11.4.6 RECESSION IMPACT 252
11.5 LATIN AMERICA 252
TABLE 272 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 253
TABLE 273 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 253
TABLE 274 LATIN AMERICA: LATERAL FLOW READERS MARKET, BY TYPE, 2020–2027 (USD MILLION) 253
TABLE 275 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 254
TABLE 276 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 254
TABLE 277 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY TYPE, 2020–2027 (USD MILLION) 255
TABLE 278 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2020–2027 (USD MILLION) 255
TABLE 279 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2020–2027 (USD MILLION) 256
TABLE 280 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY AND FERTILITY TESTING, BY TYPE, 2020–2027 (USD MILLION) 256
TABLE 281 LATIN AMERICA: LATERAL FLOW ASSAY KITS AND REAGENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 256
TABLE 282 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2020–2027 (USD MILLION) 257
TABLE 283 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET, BY END USER, 2020–2027 (USD MILLION) 257
11.5.1 BRAZIL 257
11.5.1.1 High healthcare expenditure and increasing geriatric population to drive market 257
TABLE 284 BRAZIL: MACROECONOMIC INDICATORS 258
TABLE 285 BRAZIL: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 258
TABLE 286 BRAZIL: LATERAL FLOW READERS MARKET, BY TYPE, 2020–2027 (USD MILLION) 258
TABLE 287 BRAZIL: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 259
TABLE 288 BRAZIL: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 259
TABLE 289 BRAZIL: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY TYPE, 2020–2027 (USD MILLION) 260
TABLE 290 BRAZIL: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2020–2027 (USD MILLION) 260
TABLE 291 BRAZIL: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2020–2027 (USD MILLION) 261
TABLE 292 BRAZIL: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY AND FERTILITY TESTING, BY TYPE, 2020–2027 (USD MILLION) 261
TABLE 293 BRAZIL: LATERAL FLOW ASSAY KITS AND REAGENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 261
TABLE 294 BRAZIL: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2020–2027 (USD MILLION) 262
TABLE 295 BRAZIL: LATERAL FLOW ASSAYS MARKET, BY END USER, 2020–2027 (USD MILLION) 262
11.5.2 MEXICO 262
11.5.2.1 High prevalence of obesity and related chronic diseases to propel market 262
TABLE 296 MEXICO: MACROECONOMIC INDICATORS 263
TABLE 297 MEXICO: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 263
TABLE 298 MEXICO: LATERAL FLOW READERS MARKET, BY TYPE, 2020–2027 (USD MILLION) 263
TABLE 299 MEXICO: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 264
TABLE 300 MEXICO: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 264
TABLE 301 MEXICO: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY TYPE, 2020–2027 (USD MILLION) 265
TABLE 302 MEXICO: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2020–2027 (USD MILLION) 265
TABLE 303 MEXICO: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2020–2027 (USD MILLION) 266
TABLE 304 MEXICO: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY AND FERTILITY TESTING, BY TYPE, 2020–2027 (USD MILLION) 266
TABLE 305 MEXICO: LATERAL FLOW ASSAY KITS AND REAGENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 266
TABLE 306 MEXICO: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2020–2027 (USD MILLION) 267
TABLE 307 MEXICO: LATERAL FLOW ASSAYS MARKET, BY END USER, 2020–2027 (USD MILLION) 267
11.5.3 REST OF LATIN AMERICA 267
TABLE 308 REST OF LATIN AMERICA: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 268
TABLE 309 REST OF LATIN AMERICA: LATERAL FLOW READERS MARKET, BY TYPE, 2020–2027 (USD MILLION) 268
TABLE 310 REST OF LATIN AMERICA: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 268
TABLE 311 REST OF LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 269
TABLE 312 REST OF LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY TYPE, 2020–2027 (USD MILLION) 269
TABLE 313 REST OF LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2020–2027 (USD MILLION) 270
TABLE 314 REST OF LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2020–2027 (USD MILLION) 270
TABLE 315 REST OF LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY AND FERTILITY TESTING, BY TYPE, 2020–2027 (USD MILLION) 271
TABLE 316 REST OF LATIN AMERICA: LATERAL FLOW ASSAY KITS AND REAGENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 271
TABLE 317 REST OF LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2020–2027 (USD MILLION) 271
TABLE 318 REST OF LATIN AMERICA: LATERAL FLOW ASSAYS MARKET, BY END USER, 2020–2027 (USD MILLION) 272
11.5.4 RECESSION IMPACT 272
11.6 MIDDLE EAST & AFRICA 272
11.6.1 SIGNIFICANT SUPPORT FROM GOVERNMENTS AND GLOBAL FIRMS TOWARD EXPANSION OF HEALTHCARE SERVICES TO DRIVE MARKET 272
TABLE 319 AFRICA: MACROECONOMIC INDICATORS 273
TABLE 320 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 273
TABLE 321 MIDDLE EAST & AFRICA: LATERAL FLOW READERS MARKET, BY TYPE, 2020–2027 (USD MILLION) 274
TABLE 322 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 274
TABLE 323 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 274
TABLE 324 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY TYPE, 2020–2027 (USD MILLION) 275
TABLE 325 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2020–2027 (USD MILLION) 275
TABLE 326 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2020–2027 (USD MILLION) 276
TABLE 327 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY AND FERTILITY TESTING, BY TYPE, 2020–2027 (USD MILLION) 276
TABLE 328 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY KITS AND REAGENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 276
TABLE 329 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2020–2027 (USD MILLION) 277
TABLE 330 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAYS MARKET, BY END USER, 2020–2027 (USD MILLION) 277
11.6.2 RECESSION IMPACT 277
12 COMPETITIVE LANDSCAPE 278
12.1 OVERVIEW 278
12.2 STRATEGIES ADOPTED BY KEY PLAYERS 278
FIGURE 38 OVERVIEW OF STRATEGIES ADOPTED BY MAJOR PLAYERS IN LATERAL FLOW ASSAYS MARKET 279
12.3 REVENUE SHARE ANALYSIS OF KEY PLAYERS IN LATERAL FLOW ASSAYS MARKET 279
12.4 MARKET SHARE ANALYSIS 280
FIGURE 40 LATERAL FLOW ASSAYS MARKET SHARE ANALYSIS, BY KEY PLAYER (2021) 281
12.5 R&D ASSESSMENT OF KEY PLAYERS 282
FIGURE 41 R&D EXPENDITURE: MAJOR PLAYERS IN LATERAL FLOW ASSAYS MARKET, 2020 VS. 2021 282
12.6 COMPANY EVALUATION QUADRANT FOR KEY PLAYERS 283
12.6.1 STARS 283
12.6.2 PERVASIVE PLAYERS 283
12.6.3 EMERGING LEADERS 283
12.6.4 PARTICIPANTS 283
FIGURE 42 LATERAL FLOW ASSAYS MARKET: COMPANY EVALUATION MATRIX FOR KEY PLAYERS, 2021 284
12.7 COMPANY EVALUATION QUADRANT FOR SMES AND STARTUPS 284
12.7.1 PROGRESSIVE COMPANIES 284
12.7.2 DYNAMIC COMPANIES 285
12.7.3 STARTING BLOCKS 285
12.7.4 RESPONSIVE COMPANIES 285
FIGURE 43 LATERAL FLOW ASSAYS MARKET: COMPANY EVALUATION MATRIX FOR SMES AND STARTUPS, 2021 285
12.8 COMPETITIVE BENCHMARKING 286
12.8.1 COMPANY FOOTPRINT ANALYSIS 286
TABLE 332 OVERALL COMPANY FOOTPRINT ANALYSIS (25 COMPANIES) 286
TABLE 333 PRODUCT FOOTPRINT ANALYSIS (25 COMPANIES) 287
TABLE 334 TECHNIQUE FOOTPRINT ANALYSIS (25 COMPANIES) 288
TABLE 335 APPLICATION FOOTPRINT ANALYSIS (25 COMPANIES) 289
TABLE 336 SAMPLE TYPE FOOTPRINT ANALYSIS (25 COMPANIES) 290
TABLE 337 END-USER FOOTPRINT ANALYSIS (25 COMPANIES) 292
TABLE 338 REGIONAL FOOTPRINT ANALYSIS (25 COMPANIES) 293
12.9 COMPETITIVE SCENARIO 295
12.9.1 PRODUCT LAUNCHES AND APPROVALS 295
TABLE 339 PRODUCT LAUNCHES AND APPROVALS, JANUARY 2019–DECEMBER 2022 295
12.9.2 DEALS 296
TABLE 340 DEALS, JANUARY 2019–DECEMBER 2022 296
12.9.3 OTHER DEVELOPMENTS 297
TABLE 341 OTHER DEVELOPMENTS, JANUARY 2019–DECEMBER 2022 297
13 COMPANY PROFILES 298
(Business Overview, Products/Solutions/Services Offered, Recent Developments, MnM view (Key strengths/Right to win, Strategic choices made, Weakness/competitive threats)*
13.1 KEY PLAYERS 298
13.1.1 ABBOTT LABORATORIES 298
TABLE 342 ABBOTT LABORATORIES: BUSINESS OVERVIEW 298
FIGURE 44 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2021) 299
13.1.2 F. HOFFMANN-LA ROCHE LTD. 306
TABLE 343 F. HOFFMANN-LA ROCHE LTD.: BUSINESS OVERVIEW 306
FIGURE 45 F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT (2021) 307
13.1.3 QUIDEL CORPORATION 311
TABLE 344 QUIDEL CORPORATION: BUSINESS OVERVIEW 311
FIGURE 46 QUIDEL CORPORATION: COMPANY SNAPSHOT (2021) 312
13.1.4 DANAHER CORPORATION 315
TABLE 345 DANAHER CORPORATION: BUSINESS OVERVIEW 315
FIGURE 47 DANAHER CORPORATION: COMPANY SNAPSHOT (2021) 316
13.1.5 SIEMENS AG 319
TABLE 346 SIEMENS AG: BUSINESS OVERVIEW 319
FIGURE 48 SIEMENS AG: COMPANY SNAPSHOT (2021) 320
13.1.6 BECTON, DICKINSON AND COMPANY 323
TABLE 347 BECTON, DICKINSON AND COMPANY: BUSINESS OVERVIEW 323
FIGURE 49 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2021) 324
13.1.7 BIOMÉRIEUX SA 327
TABLE 348 BIOMÉRIEUX SA: BUSINESS OVERVIEW 327
FIGURE 50 BIOMÉRIEUX SA: COMPANY SNAPSHOT (2021) 328
13.1.8 THERMO FISHER SCIENTIFIC INC. 330
TABLE 349 THERMO FISHER SCIENTIFIC INC.: BUSINESS OVERVIEW 330
FIGURE 51 THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT (2021) 331
13.1.9 PERKINELMER INC. 334
TABLE 350 PERKINELMER INC.: BUSINESS OVERVIEW 334
FIGURE 52 PERKINELMER INC.: COMPANY SNAPSHOT (2021) 335
13.1.10 QIAGEN N.V. 338
TABLE 351 QIAGEN N. V.: BUSINESS OVERVIEW 338
FIGURE 53 QIAGEN N. V.: COMPANY SNAPSHOT (2021) 339
13.2 OTHER PLAYERS 341
13.2.1 MERCK KGAA 341
TABLE 352 MERCK KGAA: BUSINESS OVERVIEW 341
FIGURE 54 MERCK KGAA: COMPANY SNAPSHOT (2021) 342
13.2.2 HOLOGIC, INC. 344
TABLE 353 HOLOGIC, INC.: BUSINESS OVERVIEW 344
FIGURE 55 HOLOGIC, INC.: COMPANY SNAPSHOT (2021) 345
13.2.3 ABCAM PLC 347
TABLE 354 ABCAM PLC: BUSINESS OVERVIEW 347
FIGURE 56 ABCAM PLC: COMPANY SNAPSHOT (2021) 348
13.2.4 SURMODICS, INC. 350
TABLE 355 SURMODICS, INC.: BUSINESS OVERVIEW 350
FIGURE 57 SURMODICS, INC.: COMPANY SNAPSHOT (2021) 350
13.2.5 CHEMBIO DIAGNOSTICS, INC. 352
TABLE 356 CHEMBIO DIAGNOSTICS, INC.: BUSINESS OVERVIEW 352
FIGURE 58 CHEMBIO DIAGNOSTICS, INC.: COMPANY SNAPSHOT (2021) 352
13.2.6 ORASURE TECHNOLOGIES 354
TABLE 357 ORASURE TECHNOLOGIES: BUSINESS OVERVIEW 354
FIGURE 59 ORASURE TECHNOLOGIES: COMPANY SNAPSHOT (2021) 355
13.2.7 DCN DIAGNOSTICS 357
TABLE 358 DCN DIAGNOSTICS: BUSINESS OVERVIEW 357
13.2.8 POLYSCIENCES INC. 358
TABLE 359 POLYSCIENCES INC.: BUSINESS OVERVIEW 358
13.2.9 ABINGDON HEALTH 359
TABLE 360 ABINGDON HEALTH: BUSINESS OVERVIEW 359
13.2.10 ORANOXIS INC. 360
TABLE 361 ORANOXIS INC.: BUSINESS OVERVIEW 360
13.2.11 AESKU.GROUP GMBH 361
TABLE 362 AESKU.GROUP GMBH: BUSINESS OVERVIEW 361
13.2.12 BIO GROUP MEDICAL SYSTEM S.R.L 362
TABLE 363 BIO GROUP MEDICAL SYSTEM S.R.L: BUSINESS OVERVIEW 362
13.2.13 PHARMACT GMBH 363
TABLE 364 PHARMACT GMBH: BUSINESS OVERVIEW 363
13.2.14 DIESSE DIAGNOSTICA SENESE S.P.A. 364
TABLE 365 DIESSE DIAGNOSTICA SENESE S.P.A.: BUSINESS OVERVIEW 364
13.2.15 XIAMEN BIOTIME BIOTECHNOLOGY CO., LTD. 365
TABLE 366 XIAMEN BIOTIME BIOTECHNOLOGY CO., LTD.: BUSINESS OVERVIEW 365
*Details on Business Overview, Products/Solutions/Services Offered, Recent Developments, MnM view (Key strengths/Right to win, Strategic choices made, Weakness/competitive threats)* might not be captured in case of unlisted companies.
14 APPENDIX 366
14.1 DISCUSSION GUIDE 366
14.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 371
14.3 CUSTOMIZATION OPTIONS 373
14.4 RELATED REPORTS 373
14.5 AUTHOR DETAILS 374

※본 조사보고서 [세계의 측방 유동 분석 시장 (~2027년) : 제품별 (키트, 리더), 용도별 (임상시험, 수의학 진단, 식품 안전 및 환경 테스트), 기술별 (샌드위치, 멀티플렉스 분석), 최종 용도별 (병원, 재택 의료)] (코드 : MD4158-23) 판매에 관한 면책사항을 반드시 확인하세요.

※본 조사보고서 [세계의 측방 유동 분석 시장 (~2027년) : 제품별 (키트, 리더), 용도별 (임상시험, 수의학 진단, 식품 안전 및 환경 테스트), 기술별 (샌드위치, 멀티플렉스 분석), 최종 용도별 (병원, 재택 의료)] 에 대해서 E메일 문의는 여기를 클릭하세요.

※당 사이트에 없는 보고서도 취급 가능한 경우가 많으니 문의 주세요!

[이하, 관련 보고서 소개]

세계의 멀티플렉스 어세이 시장 2023년-2032년 : 단백질 기반 멀티플렉스 어세이, 핵산 기반 멀티플렉스 어세이, 세포 기반 멀티플렉스 어세이
ALD24FEB158 / Allied Market Research / 2023년 11월 / 1. 소개 2. 개요 3. 시장 개요 4. 세계의 멀티플렉스 어세이 시장 규모 : 유형별 5. 세계의 멀티플렉스 어세이 시장 규모 : 제품별 6. 세계의 멀티플렉스 어세이 시장 규모 :...글로벌 멀티플렉스 어세이 시장은 2022년 36억 달러 규모로 평가되며, 2023년부터 2032년까지 연평균 7.8% 성장하여 2032년에는 77억 달러 규모에 이를 것으로 예측됩니다. 멀티플렉스 어세이는 다양한 분석 대상(단백질, 생체 분자, 성장인자, 사이토카인, 케모카인 등)을 동시에 검출 및 정량화하여 프로파일링하는 방법입니다. 이 분석법은 중합효소연쇄반응(PCR)을 통해 여러 타깃을 증폭하여 ELISA와 같은 기존 방법에 비해...

세계의 임상시험 바이오리포지토리 및 아카이브 솔루션 시장 (2023~2030) : 아카이브 솔루션, 바이오리포지토리 서비스
GRV23MR067 / Grand View Research / 2023년 2월 / 미국 Grand View Research (그랜드뷰리서치)의 본 조사 보고서는 세계의 임상시험 바이오리포지토리 및 아카이브 솔루션 시장 규모가 2023년부터 2030년 사이에 CAGR 8.3% 증가하여, 2030년에는 70억 달러에 달할 것으로 전망하고 있습니다. 본...Clinical Trial Biorepository & Archiving Solutions Market Growth & Trends The global clinical trial biorepository & archiving solutions market size is expected to reach USD 7.0 billion by 2030, registering a CAGR of 8.3%, from 2023 to 2030, according to a new report by Grand View Research, Inc. This is...

세계의 샌드위치 보드 시장예측 2025년-2031년
LPK23JU0439 / LP Information / 2025년 3월 / LPI (LP Information)의 최신 조사 보고서는 샌드위치 보드의 과거 판매실적을 살펴보고 2024년의 샌드위치 보드 판매실적을 검토하여 2025년부터 2031년까지 예상되는 샌드위치 보드 판매에 대한 지역 및 시장 세그먼트별 포괄적인 분석을 제공합니다....LPI (LP Information)' newest research report, the “Sandwich Board Industry Forecast” looks at past sales and reviews total world Sandwich Board sales in 2024, providing a comprehensive analysis by region and market sector of projected Sandwich Board sales for 2025 through 2031. With Sandwich Board sales broken down by region,...

글로벌 EPS 샌드위치 패널 시장 2025-2031
LPK23JL0612 / LP Information / 2025년 3월 / LP인포메이션 (LPI) 의 최신 조사 자료는 EPS 샌드위치 패널의 과거 판매실적을 살펴보고 2024년의 EPS 샌드위치 패널 판매실적을 검토하여 2025년부터 2031년까지 예상되는 EPS 샌드위치 패널 판매에 대한 지역 및 시장 세그먼트별...EPS Sandwich Panel is a kind of lightweight energy saving wall material, which uses cement calcium silicate or reinforced calcium silicate board as face panel, filled with cement, Expanded Polystyrene (EPS) foam particles, and as core material and forming by one time compound. LPI (LP Information)' newest research report, the...

세계의 폴리우레탄 샌드위치 패널 시장예측 2025년-2031년
LPK23JU0722 / LP Information / 2025년 3월 / LPI (LP Information)의 최신 조사 보고서는 폴리우레탄 샌드위치 패널의 과거 판매실적을 살펴보고 2024년의 폴리우레탄 샌드위치 패널 판매실적을 검토하여 2025년부터 2031년까지 예상되는 폴리우레탄 샌드위치 패널 판매에 대한 지역 및 시장 세그먼트별...Polyurethane sandwich panel is made up of two metal sheets and a rigid core in between. This rigid core has polyurethane material known for its thermal insulation properties. LPI (LP Information)' newest research report, the “Polyurethane Sandwich Panels Industry Forecast” looks at past sales and reviews total world Polyurethane Sandwich...